RBC Bioscience Corporation (TPEX:6848)

RBC Bioscience Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	211	248	210	206	459	-
Market Cap Growth	-15.58%	17.90%	2.21%	-55.24%	-	-
Enterprise Value	586	632	617	596	946	-
Last Close Price	16.25	17.08	13.75	12.60	27.27	-
PE Ratio	11.91	11.49	32.69	54.44	15.99	-
PS Ratio	1.04	1.21	1.22	1.18	1.83	-
PB Ratio	0.81	0.99	0.87	0.83	1.79	-
P/TBV Ratio	0.85	1.05	0.89	0.84	1.81	-
P/FCF Ratio	6.85	4.61	25.59	-	-	-
P/OCF Ratio	5.48	4.43	15.92	31.15	-	-
EV/Sales Ratio	2.91	3.08	3.58	3.43	3.77	-
EV/EBITDA Ratio	11.95	12.25	19.36	23.80	15.39	-
EV/EBIT Ratio	17.81	17.86	42.42	76.89	19.47	-
EV/FCF Ratio	19.04	11.75	75.08	-	-	-
Debt / Equity Ratio	1.68	1.82	1.96	1.94	1.99	0.69
Debt / EBITDA Ratio	8.89	8.59	14.17	17.82	7.51	0.60
Debt / FCF Ratio	14.17	8.45	57.42	-	-	1.38
Net Debt / Equity Ratio	1.44	1.50	1.69	1.63	1.61	-0.02
Net Debt / EBITDA Ratio	7.84	7.26	12.76	16.21	6.73	-0.02
Net Debt / FCF Ratio	12.19	6.97	49.49	-120.96	-0.87	-0.04
Asset Turnover	0.26	0.27	0.22	0.21	0.37	1.61
Inventory Turnover	2.28	2.21	2.17	2.05	2.40	6.40
Quick Ratio	0.77	0.85	0.89	0.83	0.83	0.64
Current Ratio	1.29	1.41	1.41	1.27	1.41	1.07
Return on Equity (ROE)	7.70%	8.80%	2.63%	1.49%	13.31%	108.13%
Return on Assets (ROA)	2.69%	2.91%	1.18%	0.59%	4.47%	32.90%
Return on Invested Capital (ROIC)	4.07%	4.45%	1.82%	0.90%	9.23%	106.04%
Return on Capital Employed (ROCE)	5.10%	5.40%	2.20%	1.20%	6.90%	83.30%
Earnings Yield	9.29%	8.70%	3.06%	1.84%	6.25%	-
FCF Yield	14.61%	21.71%	3.91%	-1.63%	-103.39%	-
Dividend Yield	1.85%	2.98%	2.91%	8.08%	3.03%	-
Payout Ratio	66.23%	60.16%	226.02%	312.23%	50.06%	38.59%
Buyback Yield / Dilution	-0.34%	-0.43%	0.08%	-5.81%	-2.28%	-4.32%
Total Shareholder Return	1.51%	2.55%	2.99%	2.27%	0.75%	-4.32%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.